Skip to main content
Journal cover image

Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small-cell lung cancer.

Publication ,  Journal Article
Speicher, PJ; Englum, BR; Ganapathi, AM; Onaitis, MW; D'Amico, TA; Berry, MF
Published in: Eur J Cardiothorac Surg
April 2015

OBJECTIVES: Treatment patterns and outcomes in a population-based database were examined to identify patients likely to benefit from surgical resection of locally advanced (T3N0-2) non-small-cell lung cancer (NSCLC). METHODS: Factors predicting the use of surgery for patients with T3N0-2M0 NSCLC in the Surveillance, Epidemiology and End Results (SEER) database from 1988 to 2010 were assessed using a multivariable logistic regression model. Survival was analysed using the Kaplan-Meier approach and Cox proportional hazard models. Propensity matching was used to compare outcomes after surgery and outcomes in patients who refused surgery and underwent radiation therapy (RT). RESULTS: Of 17 378 patients identified for study inclusion [8597 (50%) T3N0, 2304 (13%) T3N1 and 6477 (37%) T3N2], surgery was used in 7120 (41%). Only female sex and being married predicted the use of surgery, while older age, black race and N2 nodal disease predicted non-surgical management. Surgical patients overall had better long-term survival than non-surgical patients [odds ratio (OR) 0.42, 95% confidence interval (CI): 0.41-0.45, P < 0.001]. After propensity adjustment, patients who refused surgery and instead were treated with RT had significantly worse long-term survival than matched surgery patients (OR 0.65, 95% CI: 0.48-0.89, P = 0.0074). Sublobar resection and pneumonectomy predicted worse survival in patients who had surgery. Nodal disease also predicted worse survival after surgery, but surgery maintained an association with better overall survival compared with non-operative therapy among patients with both N1 (OR 0.53, P < 0.001) and N2 disease (OR 0.50, P < 0.001) in separate analyses stratified by nodal status. Older age also predicted worse survival after surgery, but patients older than 75 who were treated with surgery had significantly better long-term survival than non-operative patients (OR 0.49, 95% CI: 0.45-0.53, P < 0.001). CONCLUSIONS: Surgery is used in a minority of patients with locally advanced NSCLC, but is associated with better survival than non-surgical treatment, even for patients older than 75 and patients with nodal disease. Given the very poor outcomes observed with non-operative management, surgical resection should be carefully considered in all patients with locally advanced NSCLC and should not necessarily be denied because of patient age or nodal disease.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Eur J Cardiothorac Surg

DOI

EISSN

1873-734X

Publication Date

April 2015

Volume

47

Issue

4

Start / End Page

636 / 641

Location

Germany

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Respiratory System
  • Pneumonectomy
  • Middle Aged
  • Male
  • Lung Neoplasms
  • Kaplan-Meier Estimate
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Speicher, P. J., Englum, B. R., Ganapathi, A. M., Onaitis, M. W., D’Amico, T. A., & Berry, M. F. (2015). Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small-cell lung cancer. Eur J Cardiothorac Surg, 47(4), 636–641. https://doi.org/10.1093/ejcts/ezu270
Speicher, Paul J., Brian R. Englum, Asvin M. Ganapathi, Mark W. Onaitis, Thomas A. D’Amico, and Mark F. Berry. “Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small-cell lung cancer.Eur J Cardiothorac Surg 47, no. 4 (April 2015): 636–41. https://doi.org/10.1093/ejcts/ezu270.
Speicher PJ, Englum BR, Ganapathi AM, Onaitis MW, D’Amico TA, Berry MF. Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small-cell lung cancer. Eur J Cardiothorac Surg. 2015 Apr;47(4):636–41.
Speicher, Paul J., et al. “Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small-cell lung cancer.Eur J Cardiothorac Surg, vol. 47, no. 4, Apr. 2015, pp. 636–41. Pubmed, doi:10.1093/ejcts/ezu270.
Speicher PJ, Englum BR, Ganapathi AM, Onaitis MW, D’Amico TA, Berry MF. Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small-cell lung cancer. Eur J Cardiothorac Surg. 2015 Apr;47(4):636–641.
Journal cover image

Published In

Eur J Cardiothorac Surg

DOI

EISSN

1873-734X

Publication Date

April 2015

Volume

47

Issue

4

Start / End Page

636 / 641

Location

Germany

Related Subject Headings

  • Treatment Outcome
  • Retrospective Studies
  • Respiratory System
  • Pneumonectomy
  • Middle Aged
  • Male
  • Lung Neoplasms
  • Kaplan-Meier Estimate
  • Humans
  • Female